Certain area residents are eligible for a third COVID-19 vaccine dose if they have previously received either the Pfizer or Moderna shots.
The Tennessee Department of Health, based on recent guidance from the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), has recommended an additional dose of the COVID-19 mRNA vaccine for moderately and severely immunocompromised individuals.
On Aug. 13, the CDC accepted ACIP recommendations for an additional dose of the mRNA COVID-19 vaccine. This includes approval for a third dose of the Pfizer-BioNTech COVID-19 Vaccine (approved for individuals age 12 years and above) and the Moderna COVID-19 Vaccine (approved for individuals age 18 years and above).
The recommendation from the CDC does not include approval for an additional dose of the Johnson & Johnson vaccine.
TDH recommends that Tennesseans talk with their health care provider about their medical condition and whether getting an additional dose is appropriate for them.
Based on the recommendations from the FDA and CDC, moderately and severely immunocompromised individuals, are defined as:
• Receiving active cancer treatment for tumors or cancers of the blood
• Received an organ transplant and are taking medicine to suppress the immune system
• Received a stem cell transplant within the last two years or are taking medicine to suppress the immune system
• Moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome)
• Advanced or untreated HIV infection
• Active treatment with high-dose corticosteroids or other drugs that may suppress immune response
A notification has been sent to all Tennessee providers with information on these recommendations. Providers can begin offering the additional dose option to eligible patients.
Visit www.vaccines.gov to find a vaccine site offering the Pfizer or Moderna vaccine. Patients do not need to prove their diagnosis to be eligible for an additional vaccine dose.
Local health departments across the state will be administering the additional dose option with no appointment necessary.